ATE325620T1 - Streptococcus pneumoniae proteine und impfstoffe - Google Patents
Streptococcus pneumoniae proteine und impfstoffeInfo
- Publication number
- ATE325620T1 ATE325620T1 AT00939739T AT00939739T ATE325620T1 AT E325620 T1 ATE325620 T1 AT E325620T1 AT 00939739 T AT00939739 T AT 00939739T AT 00939739 T AT00939739 T AT 00939739T AT E325620 T1 ATE325620 T1 AT E325620T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines
- streptococcus pneumoniae
- pneumoniae proteins
- polypeptides
- relates
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000193998 Streptococcus pneumoniae Species 0.000 title abstract 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000035109 Pneumococcal Infections Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13845399P | 1999-06-10 | 1999-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE325620T1 true ATE325620T1 (de) | 2006-06-15 |
Family
ID=22482080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00939739T ATE325620T1 (de) | 1999-06-10 | 2000-06-09 | Streptococcus pneumoniae proteine und impfstoffe |
| AT06009322T ATE500843T1 (de) | 1999-06-10 | 2000-06-09 | Streptococcus pneumoniae proteine und impfstoffe |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06009322T ATE500843T1 (de) | 1999-06-10 | 2000-06-09 | Streptococcus pneumoniae proteine und impfstoffe |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1185297B1 (enExample) |
| JP (1) | JP2003501110A (enExample) |
| AT (2) | ATE325620T1 (enExample) |
| AU (1) | AU777856B2 (enExample) |
| CA (1) | CA2371714C (enExample) |
| DE (2) | DE60027890T2 (enExample) |
| ES (2) | ES2264419T3 (enExample) |
| HK (1) | HK1043943A1 (enExample) |
| WO (1) | WO2000076540A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135560B1 (en) | 1997-07-02 | 2006-11-14 | Sanofi Pasteur Limited | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| AU2002351623A1 (en) | 2001-12-20 | 2003-07-09 | Shire Biochem Inc. | Streptococcus antigens |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| PL3017827T3 (pl) | 2005-12-22 | 2019-04-30 | Glaxosmithkline Biologicals Sa | Szczepionka z koniugatem polisacharydu pneumokokowego |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| US9610339B2 (en) | 2007-06-26 | 2017-04-04 | Glaxosmithkline Biologicals, S.A. | Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| NZ586367A (en) | 2007-12-13 | 2012-04-27 | Intervacc Ab | Improved immunizing composition comprising an antigen from Streptococcus equi |
| PL2268618T3 (pl) | 2008-03-03 | 2015-11-30 | Novartis Ag | Związki i kompozycje jako modulatory aktywności receptorów TLR |
| PL2271360T3 (pl) | 2008-04-16 | 2016-03-31 | Glaxosmithkline Biologicals Sa | Szczepionka |
| CN102762226A (zh) | 2009-06-10 | 2012-10-31 | 诺华有限公司 | 含苯并萘啶的疫苗 |
| MX2012000158A (es) | 2009-06-29 | 2012-06-08 | Genocea Biosciences Inc | Vacunas y composiciones contra streptococcus pneumoniae. |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| US20120237536A1 (en) | 2009-09-10 | 2012-09-20 | Novartis | Combination vaccines against respiratory tract diseases |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| US9408907B2 (en) | 2009-12-15 | 2016-08-09 | Glaxosmithkline Biologicals Sa | Homogenous suspension of immunopotentiating compounds and uses thereof |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP5848748B2 (ja) | 2010-03-23 | 2016-01-27 | アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ | 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物 |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| CN105833260A (zh) | 2011-01-20 | 2016-08-10 | 健诺西生物科学公司 | 针对肺炎链球菌（Streptococcus Pneumoniae）的疫苗和组合物 |
| BR112013029514A2 (pt) | 2011-05-17 | 2019-09-24 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, e, método de tratar ou impedir uma doença |
| JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| TR201807340T4 (tr) | 2013-02-01 | 2018-06-21 | Glaxosmithkline Biologicals Sa | Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi. |
| IL276608B2 (en) | 2018-02-12 | 2024-04-01 | Inimmune Corp | Toll-like receptor ligands |
| JP2023547676A (ja) | 2020-11-04 | 2023-11-13 | エリゴ・バイオサイエンス | ＤＮＡペイロードをアクネ菌集団へとｉｎ ｓｉｔｕ送達するためのファージ由来粒子 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018931A2 (en) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
| EP1144640A3 (en) * | 1998-07-27 | 2001-11-28 | Microbial Technics Limited | Nucleic acids and proteins from streptococcus pneumoniae |
-
2000
- 2000-06-09 ES ES00939739T patent/ES2264419T3/es not_active Expired - Lifetime
- 2000-06-09 CA CA2371714A patent/CA2371714C/en not_active Expired - Fee Related
- 2000-06-09 ES ES06009322T patent/ES2360296T3/es not_active Expired - Lifetime
- 2000-06-09 DE DE60027890T patent/DE60027890T2/de not_active Expired - Lifetime
- 2000-06-09 JP JP2001502873A patent/JP2003501110A/ja active Pending
- 2000-06-09 AT AT00939739T patent/ATE325620T1/de not_active IP Right Cessation
- 2000-06-09 AT AT06009322T patent/ATE500843T1/de not_active IP Right Cessation
- 2000-06-09 DE DE60045721T patent/DE60045721D1/de not_active Expired - Lifetime
- 2000-06-09 EP EP00939739A patent/EP1185297B1/en not_active Expired - Lifetime
- 2000-06-09 WO PCT/US2000/015925 patent/WO2000076540A2/en not_active Ceased
- 2000-06-09 EP EP06009322A patent/EP1731166B1/en not_active Expired - Lifetime
- 2000-06-09 HK HK02105081.7A patent/HK1043943A1/zh unknown
- 2000-06-09 AU AU54778/00A patent/AU777856B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60045721D1 (de) | 2011-04-21 |
| WO2000076540A3 (en) | 2001-02-08 |
| HK1043943A1 (zh) | 2002-10-04 |
| EP1731166A3 (en) | 2007-02-21 |
| DE60027890D1 (de) | 2006-06-14 |
| ES2264419T3 (es) | 2007-01-01 |
| EP1731166A2 (en) | 2006-12-13 |
| CA2371714C (en) | 2012-12-04 |
| EP1185297B1 (en) | 2006-05-10 |
| JP2003501110A (ja) | 2003-01-14 |
| EP1731166B1 (en) | 2011-03-09 |
| EP1185297A2 (en) | 2002-03-13 |
| WO2000076540A2 (en) | 2000-12-21 |
| ES2360296T3 (es) | 2011-06-02 |
| CA2371714A1 (en) | 2000-12-21 |
| DE60027890T2 (de) | 2007-04-19 |
| ATE500843T1 (de) | 2011-03-15 |
| AU5477800A (en) | 2001-01-02 |
| AU777856B2 (en) | 2004-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE325620T1 (de) | Streptococcus pneumoniae proteine und impfstoffe | |
| NZ512574A (en) | Novel streptococcus antigens useful as vaccines | |
| WO2001098334A3 (en) | Streptococcus antigens | |
| ATE422899T1 (de) | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe | |
| EP2067863A3 (en) | Methods and compositions for diseases associated with amyloidosis | |
| ATE276758T1 (de) | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid | |
| MY125202A (en) | Vaccine | |
| DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
| ATE252640T1 (de) | Verbindungen zur immunotherapie und diagnose von tuberkulose | |
| DK0778781T3 (da) | Pneumokok-polysaccharid-rekombinant pneumolysin-konjugat-vacciner til immunisering mod pneumokokinfektioner | |
| WO2001081380A3 (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
| WO1999042076A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| WO1999042588A3 (en) | Group b streptococcus antigens | |
| NO20015074D0 (no) | Nye sammensetninger | |
| DE60037900D1 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
| WO2002045742A8 (en) | Lipoteichoic acid immunogenic compositions and methods of making and using thereof | |
| WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
| EA200100700A1 (ru) | Гены и белки и их применение | |
| BR0207447A (pt) | Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina | |
| EA200100701A1 (ru) | Белки наружной поверхности, их гены и их применение | |
| DE60234772D1 (de) | Gruppe-b streptococcus antigene und entsprechende dna-fragmente | |
| ATE401341T1 (de) | Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |